Anne E. White
CIK 1752313 · EVP & Pres, Lilly Neuroscience · last filed 2025-02-12
Anne E. White is an EVP & Pres, Lilly Neuroscience who has filed 13 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider was granted $5.9M of LLY on Feb 12, 2025. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $84.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$84.08M
1
13
-$1.61M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LLY | EVP & Pres, Lilly Neuroscience | 74,209 | $1133.00 | $84.08M | -$1.61M | 13 | 2025-02-12 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-12 | LLY | Grant (A) | +6,828 | $5.93M | EDGAR |
| 2025-02-04 | LLY | Mixed | +1,811 | -$1.18M | EDGAR |
| 2024-02-14 | LLY | Grant (A) | +5,363 | $3.95M | EDGAR |
| 2024-02-02 | LLY | Mixed | +2,280 | -$1.19M | EDGAR |
| 2023-02-14 | LLY | Mixed | +3,562 | $1.23M | EDGAR |
| 2023-02-03 | LLY | Mixed | +4,012 | -$1.12M | EDGAR |
| 2022-02-11 | LLY | Grant (A) | +11,348 | $2.76M | EDGAR |
| 2022-02-03 | LLY | Mixed | +5,164 | -$1.03M | EDGAR |
| 2021-02-10 | LLY | Grant (A) | +4,718 | $970.8K | EDGAR |
| 2020-02-13 | LLY | Grant (A) | +7,079 | $1.02M | EDGAR |